FDA approves new treatment for advanced prostate cancer
WEBJul 12, 2023 · In June, the FDA approved a new treatment for the most advanced type of prostate cancer. Patients who have this condition, which is called metastatic castration-resistant prostate cancer (mCRPC), have few therapeutic options, so the approval helps to fill an urgent need.
Xtandi Approved for High-Risk Prostate Cancer - NCI
WEBJan 5, 2024 · Enzalutamide (Xtandi) can now be used alone or combined with leuprolide to treat some people with prostate cancer who have had a biochemical recurrence.
FDA Approves Promising Therapy for Advanced Prostate Cancer ...
WEBMar 23, 2022 · Prostate cancer treatment took a major step forward today as the U.S. Food and Drug Administration approved a new therapy that zeros in on cancer cells to destroy them. The treatment, called 177 Lu-PSMA-617, uses a molecule that selectively seeks out and attaches to a specific protein on the cancer cell surface called PSMA (prostate-specific ...
Prostate Cancer News - ScienceDaily
WEBAug 22, 2024 · Learn the symptoms of prostate cancer. Read current medical research on new treatment options, vaccines, surgery and prevention.
Study shows equal effectiveness of proton beam therapy and ...
WEB2 days ago · Between June 2012 and November 2021, Dr. Efstathiou and his colleagues randomly assigned 450 patients with low- or intermediate-risk localized prostate cancer enrolled from 29 recruiting centers ...
A Promising New Therapy for Advanced Prostate Cancer
WEBJun 3, 2021 · Prostate cancer treatment stands on the brink of a major advance with the development of a new treatment that zeros in on cancer cells to destroy them. The therapy, called 177 Lu-PSMA-617, uses a molecule that selectively seeks out and attaches to a specific protein on the cancer cell surface.
IMRT and proton therapy offer equally high quality of life ...
WEB2 days ago · About 70% of new prostate cancer cases — more than 200,000 people in the U.S. each year — are diagnosed as localized disease. And since many of these patients will survive their cancer and live many years after treatment, their quality of life becomes particularly paramount when making treatment decisions, Dr. Efstathiou said.
FDA Approves Relugolix for Advanced Prostate Cancer
WEBJan 26, 2021 · A new drug approved by the Food and Drug Administration (FDA) is expected to immediately affect the treatment of some men with prostate cancer. In a large clinical trial, the drug, relugolix (Orgovyx), was shown to be more effective at reducing testosterone levels in men with advanced prostate …
New radiation therapy for prostate cancer reduces deaths ...
WEBJun 3, 2021 · The trial was investigating a new, potentially groundbreaking type of treatment for prostate cancer, a therapy that specifically targets a protein on the cancer cells.
Talazoparib Combo Approved for Metastatic Prostate Cancer
WEBAug 4, 2023 · FDA based the approval of enzalutamide (Xtandi) plus talazoparib (Talzenna) on a large clinical trial that showed the combination was more effective than enzalutamide alone in treating men with metastatic castration-resistant prostate cancer.